Ancillary techniques, such as immunohistochemistry for p57kip2 (which is absent in CHM due to its androgenetic origin), and ploidy analysis via flow cytometry or molecular karyotyping, can help differentiate a CHM from a partial mole or other placental abnormalities. The gene discussed is CDKN1C; the disease is melanocytic nevus.